Cynthia Reyes, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1011 W Grove St, Kaufman, TX 75142 Phone: 972-932-1319 Fax: 972-932-1396 |
Sara L Zaleta, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 874 Ed Hall Dr Ste B-108, Kaufman, TX 75142 Phone: 972-932-5555 Fax: 972-932-5557 |
Dr. Charles Turner Lewis Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1011 W Grove St, Ste 100, Kaufman, TX 75142 Phone: 972-932-1319 Fax: 972-932-1388 |
News Archive
Food security is a global challenge especially in developing countries with a growing population and less land to cultivate. Erratic weather patterns due to global warming in the recent years have increased uncertainty in the productivity of agricultural produce particularly in mountainous regions.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of its first twelve tests in a new line of "liquid biopsy" or NeoLAB assays using next generation sequencing and other advanced molecular technologies.
By employing optogenetics, a new field that uses genetically altered cells to respond to light, and a tandem unit cell (TCU) strategy, researchers at Stony Brook University have demonstrated a way to control cell excitation and contraction in cardiac muscle cells, the details of which are published in the early online edition of Circulation: Arrhythmia & Electrophysiology: "Stimulating Cardiac Muscle by Light: Cardiac Optogenetics by Cell Delivery."
Mild heart failure patients with a particular condition that results in disorganized electrical activity throughout the heart benefit substantially from cardiac resynchronization therapy with defibrillator (CRT-D), according to a study published in the American Heart Association journal Circulation.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that, effective immediately, its Board of Directors has approved a repurchase program for up to $10 million in shares of the Company's common stock over a twelve month period.
› Verified 4 days ago